comparemela.com

Latest Breaking News On - Brianm culley - Page 4 : comparemela.com

Lineage Announces Issuance of U S Patent Covering Proprietary Manufacturing and Differentiation Process for Retinal Pigmented Epithelial Cells

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the United States Patent and Trademark.

United statesBrianm culleyRoche groupExchange commissionTrademark officeLineage cell therapeutics incLineage cell therapeuticsUnited states patentScale productionRetinal pigment epithelialCell therapeuticsAnnual report

Lineage to Present at Cantor Fitzgerald 2023 Global Healthcare Conference on September 27, 2023

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Brian M. Culley, Lineage’s Chief.

United statesKristen kluskaBrianm culleyBiotechnology equity researchLineage cell therapeutics incRoche groupIntercontinental new york barclay hotelCantor fitzgerald coCantor fitzgeraldLineage cell therapeuticsChief executive officerHealthcare conferenceManaging directorIntercontinental new york barclayCell therapeutics

Lineage Cell Therapeutics : Results of Annual Meeting was held on September 6, 2023 -Today at 03:01 am

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT .

United statesGeorgea samuelBrianm culleyAngusc russellDon baileyNealc bradsherDipti aminAnula jayasuriyaMichaelh mulroyDeborah andrewsAlfredd kingsleyLineage cell therapeutics incSecurities exchangeExchange commission onMeeting of lineage cell therapeutics incSecurities exchange act

Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics

Lineage Cell Therapeutics, Inc. ; class= js-l-obf link link blue

United statesMatt angelBrianm culleyRoche groupEterna therapeutics incFactor bioscience incExchange commissionLineage cell therapeutics incLineage cell therapeuticsEterna therapeuticsChief executive officerCell therapeuticsFactor bioscienceAnnual reportQuarterly report

Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held September 6, 2023

UNITED STATES .

United statesBrianm culleyExchange actExchange commissionBoard of lineage cell therapeutics incMeeting of lineage cell therapeutics incEq shareowner servicesLineage cell therapeutics incShareholders of lineage cell therapeutics incSecurities exchangeStatement pursuantSecurities exchange actCommission onlyMaterial pursuantCell therapeuticsIts charter

vimarsana © 2020. All Rights Reserved.